Microporous nanofibrous fibrin-based scaffolds for bone tissue engineering.
The fibrotic response of the body to synthetic polymers limits their success in tissue engineering and other applications. Though porous polymers have demonstrated improved healing, difficulty in controlling their pore sizes and pore interconnections has clouded the understanding of this phenomenon. In this study, a novel method to fabricate natural polymer/calcium phosphate composite scaffolds with tightly controllable pore size, pore interconnection, and calcium phosphate deposition was developed. Microporous, nanofibrous fibrin scaffolds were fabricated using sphere-templating methods. Composite scaffolds were created by solution deposition of calcium phosphate on fibrin surfaces or by direct incorporation of nanocrystalline hydroxyapatite (nHA). The SEM results showed that fibrin scaffolds exhibited a highly porous and interconnected structure. Osteoblast-like cells, obtained from murine calvaria, attached, spread and showed a polygonal morphology on the surface of the biomaterial. Multiple cell layers and fibrillar matrix deposition were observed. Moreover, cells seeded on mineralized fibrin scaffolds exhibited significantly higher alkaline phosphatase activity as well as osteoblast marker gene expression compared to fibrin scaffolds and nHA incorporated fibrin scaffolds (0.25 and 0.5g). All types of scaffolds were degraded both in vitro and in vivo. Furthermore, these scaffolds promoted bone formation in a mouse calvarial defect model and the bone formation was enhanced by addition of rhBMP-2.
Osathanon
Thanaphum
T
Department of Oral Biology, School of Dentistry, University of Washington, Seattle, WA 98195, United States.
Linnes
Michael L
ML
Rajachar
Rupak M
RM
Ratner
Buddy D
BD
Somerman
Martha J
MJ
Giachelli
Cecilia M
CM
D000818:Animals; D018929:Cell Culture Techniques; D002478:Cells, Cultured; D005337:Fibrin / Q000737:chemistry* / Q000494:pharmacology*; D008422:Materials Testing; D051379:Mice; D008810:Mice, Inbred C57BL; D049329:Nanostructures / Q000008:administration & dosage* / Q000737:chemistry* / Q000648:ultrastructure; D010006:Osteoblasts / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D010012:Osteogenesis / Q000502:physiology*; D016062:Porosity; D013499:Surface Properties; D023822:Tissue Engineering / Q000379:methods*
D005337:Fibrin